Anti-arrhythmic effects of prazosin and propranolol during coronary artery occlusion and re-perfusion in dogs and pigs

British Journal of Pharmacology
B G BenfeyD R Varma


Open-chest dogs and pigs anaesthetized with pentobarbitone were used to evaluate the anti-arrhythmic effect of prazosin and propranolol during a 30 min period of occlusion of the left anterior descending coronary artery followed by 15 min of re-perfusion. In dogs, both prazosin and propranolol reduced the incidence of ventricular premature depolarizations and ventricular tachycardia during the occlusion period. During the 45 min period of occlusion and re-perfusion, the incidence of ventricular fibrillation was significantly reduced in the prazosin-treated and propranolol-treated dogs. In pigs prazosin reduced the incidence of ventricular premature depolarizations during occlusion and propranolol reduced the incidence of both ventricular premature depolarizations and ventricular tachycardia during occlusion, but the incidence of ventricular fibrillation was not significantly reduced in the prazosin- and propranolol-treated pigs. Prazosin reduced arterial pressure and propranolol lowered heart rate in both dogs and pigs, but a comparison of mean arterial pressure and heart rate in animals surviving and those not surviving the 30 min of coronary artery occlusion and 15 min of re-perfusion showed no significant difference.


Nov 1, 1979·The Journal of Clinical Investigation·A MukherjeeJ T Willerson
Nov 1, 1975·The American Journal of Cardiology·H BrooksL Resnekov
Aug 1, 1971·Life Sciences. Pt. 1: Physiology and Pharmacology·M De Brabander, W Schaper
Jan 1, 1972·British Heart Journal·A ArmstrongS L Morrison
Dec 1, 1966·American Heart Journal·B L Pentecost, W G Austen
Feb 1, 1983·British Heart Journal·D A Chamberlain
Jan 1, 1980·The Journal of Clinical Investigation·D J SheridanP B Corr
Mar 1, 1982·Progress in Cardiovascular Diseases·R R MillerM A Quinones
Feb 1, 1983·American Heart Journal·T FujimotoW J Mandel
Jan 1, 1981·Progress in Cardiovascular Diseases·J F PantridgeA A Adgey
Apr 1, 1982·American Heart Journal·E S Kirk, E H Sonnenblick
Oct 1, 1982·Circulation Research·M W Gorman, H V Sparks
Dec 11, 1980·The New England Journal of Medicine·D E Gregg, R E Patterson


Dec 3, 1990·Molecular and Cellular Biochemistry·T KawaiT Satake
Apr 1, 1991·Integrative Physiological and Behavioral Science : the Official Journal of the Pavlovian Society·J E Skinner
Jan 1, 1991·Journal of Tongji Medical University = Tong Ji Yi Ke Da Xue Xue Bao·A R ZouH Pei
Oct 16, 2010·Naunyn-Schmiedeberg's Archives of Pharmacology·Jacek SapaKatarzyna Kulig
May 20, 1985·European Journal of Pharmacology·P D VerdouwW J Van der Giessen
Aug 7, 1986·European Journal of Pharmacology·D J WilberB R Lucchesi
Apr 17, 1991·European Journal of Pharmacology·H TodtG Raberger
Jan 1, 1985·Molecular Aspects of Medicine·J H BottingM J Walker
May 1, 1990·Journal of Pharmacological Methods·A W Gomoll, R F Lekich
Jul 1, 1989·Journal of the American College of Cardiology·J CincaA Salas-Caudevilla
Dec 1, 1989·British Journal of Pharmacology·B A MacLeodM J Walker
Jan 1, 1994·Journal of Cardiovascular Electrophysiology·E VanoliP J Schwartz
Jan 1, 1991·The Journal of Pharmacy and Pharmacology·J P SpiersR Wilson
Nov 26, 1986·The American Journal of Cardiology·P D VerdouwP G Hugenholtz
Jan 1, 1989·Fundamental & Clinical Pharmacology·D LamontagneJ De Champlain
Jan 1, 1990·International Journal of Cardiology·C J MurdockR R Taylor
Nov 1, 1993·Clinical and Experimental Pharmacology & Physiology·T YamamotoT Karasawa
Oct 1, 1988·British Journal of Pharmacology·L M SassenP D Verdouw
Jan 1, 1990·Life Sciences·B G Benfey

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.